🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to determine whether ATIR is safe and effectiv...
Status
Completed
Location
Algemeen Ziekenhuis Sint-Jan
Start Date
2013-03
Trial ID
NCT01794299
Treatments Being Tested
RATIONALE: Chemotherapy, such as busulfan, melphalan, and thiotepa, may des...
Status
Completed
Location
Knight Cancer Institute at Oregon Health and Science University
Start Date
2005-03
Trial ID
NCT00238433
No prospective randomized trials have evaluated the most efficacious dose o...
Status
Completed
Location
Dartmouth Hitchcock Medical Center
Start Date
2013-12
Trial ID
NCT02139280
Treatments Being Tested
The purposes of the study are to determine the maximum tolerated dose (MTD)...
Status
Active Not Recruiting
Location
Moffitt Cancer Center
Start Date
2022-03-21
Trial ID
NCT05015426
Treatments Being Tested
Outcomes for patients with severe aplastic anemia (SAA) who are refractory ...
Status
Recruiting
Location
CHU Amiens
Start Date
2022-01-06
Trial ID
NCT05126849
Treatments Being Tested
This study aims to evaluate the safety, feasibility, and preliminary effica...
Status
Not Yet Recruiting
Location
Institute of Hematology & Blood Diseases Hospital, China
Start Date
2026-08-01
Trial ID
NCT07757685
Treatments Being Tested
This is a phase II trial using a non-myeloablative cyclophosphamide/ fludar...
Status
Completed
Location
Masonic Cancer Center at University of Minnesota
Start Date
2017-03-09
Trial ID
NCT02661035
This phase I trial studies the side effects and best dose of genetically mo...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2013-10-08
Trial ID
NCT01815749
Evaluation of the safety and efficacy of 3 x 10, 3 x 12 or 3 x 14 g/m² Treo...
Status
Completed
Location
Helsinki University Central Hospital
Start Date
2001-11
Trial ID
NCT01063647
Treatments Being Tested
Severe congenital neutropenia (SCN) is a group of primary immunodeficiencie...
Status
Unknown
Location
HSCT department
Start Date
2021-04-14
Trial ID
NCT04844177
Treatments Being Tested